Get startedLog in
    Picture of Pangaea Oncology SA logo

    PANG — Pangaea Oncology SA Cashflow Statement

    0.000.00%
    es flag iconLast trade - 00:00
    HealthcareBalancedMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Pangaea Oncology SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

    2019
    December 31st
    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    SAS
    SAS
    SAS
    SAS
    SAS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-4.98-1.91-1.1-2.84-3.51
    Depreciation
    Amortisation
    Non-Cash Items0.162-2.1-1.52-1.88-1.41
    Unusual Items
    Equity in Net Earnings/Losses
    Other Non-Cash Items
    Changes in Working Capital-0.655-0.321-0.873-0.1950.702
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-2.4-1.92-2.5-3.68-2.4
    Capital Expenditures-0.001-0.071-0.03-0.02-0.291
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-0.019-0.119-0.768-0.725-1.29
    Acquisition of Business
    Sale/Maturity of Investment
    Change in Net Investments
    Purchase of Investments
    Cash from Investing Activities-0.02-0.19-0.797-0.746-1.58
    Financing Cash Flow Items————0.067
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities2.092.045.089.5-1.74
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-0.328-0.0881.775.08-5.72